This year, two nonprofit organizations will each receive a $50,000 USD grant to fund projects that advance equity, accessibility and inclusion for individuals with Duchenne. Entrada will award one grant to a U.S.-based nonprofit and another to a nonprofit in the UK or EU.
DREAMS Grant Program

DREAMS For Duchenne
Launched in 2023, Entrada DREAMS is a competitive annual grant program designed to fund efforts within the Duchenne muscular dystrophy community to better identify, understand and reach those who are currently underrepresented and underserved.
DREAMS and Belonging
Entrada is building a company culture where everyone can belong, contribute and grow. In the same way, we are committed to working toward a healthcare system that is equitable and inclusive. Entrada DREAMS is part of our commitment to support Duchenne-focused non-profit organizations in their efforts to address disparities in healthcare and to better serve all people living with Duchenne.
DREAMS and Impact
DREAMS has funded transformative projects that bridge healthcare disparities and strengthen community connections. Keep reading to learn more about past recipients and their projects.
Applications close at 11:59 PM EST on June 9, 2025
Or click here for additional information and program requirements.Following Their DREAMS
2023 DREAMS Grant Recipients: Where Are They Now?
Hear from the 2023 DREAMS Grant recipients on their progress made for the Duchenne muscular dystrophy community since receiving the inaugural Entrada DREAMS Grant.

A spotlight on The Akari Foundation
Read their story
A spotlight on Parent Project Muscular Dystrophy
Read their story
A spotlight on Neurology and Neuromuscular Care Center
Read their storyMeet our 2025 Independent Grant Review Committee

Sean Baumstark
Founder, determinence Podcast Co-Host, Two Disabled Dudes

Keisha Greaves
CEO & Founder, Girls Chronically Rock

Amaris Sánchez-Larragoity, PsyD
Psychologist

Aravindhan Veerapandiyan, MD
Pediatric Neurologist, Arkansas Children’s Hospital
Program Info and Requirements
To apply, your organization must be a non-profit that either:
1. Provides services to people with Duchenne muscular dystrophy, or
2. Will work directly with the Duchenne community as part of this grant
Non-profits in the US, UK and EU are eligible to apply - you'll need to provide documents to confirm your non-profit status.
EU countries include Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden
As a first step, you will need to complete the Interest Form.
Atter the Interest Form has been submitted, it will be reviewed for eligibility. All applicants will receive a response. If you are eligible, you will receive an email with a link to the final application.
For the final application, you will need to provide detailed information about your project, including:
• Your project's goals and objectives
• The specific needs it addresses within the Duchenne community
• A clear plan for implementation and outreach
Only one application per non-profit organization will be considered. A written agreement, defining the basic conditions of the grant, will be entered between Entrada Therapeutics and the award recipients.
Final applications must be submitted by 11:59 PM on June 9, 2025.
Review Criteria
All applications will be anonymized and prepared for evaluation by Independent Grant Review Committee, which consists of neuromuscular specialists and patient advocates. Each application will be anonymized and reviewed, scored, and ranked using the following criteria:
How clearly does the project align with the mission of promoting inclusivity, equity and accessibility within the Duchenne community?
How well does the project identify and address critical needs in the Duchenne community – particularly those faced by historically underrepresented groups – through accessible, impactful services or solutions?
To what extent does the project demonstrate potential for long-term, transformative impact through meaningful partnerships with historically underrepresented and/or local community groups?
How clear and feasible is the project’s implementation plan, including timeline, key activities and strategies for engaging the Duchenne community?
How strong is the project’s overall impact strategy, including defined outcomes, methods for evaluation and potential long-term, transformative change for individuals within the Duchenne community?
To what extent does the organization demonstrate and/or aim to demonstrate the experience, partnerships and resources necessary to effectively serve the Duchenne community, including historically underrepresented populations?
How detailed, realistic and aligned is the proposed budget in supporting the goals and implementation of the project?
Resources
Organizations seeking guidance to prepare an application may find the resources listed below helpful: